Qualification of Drivers; Exemption Applications; Implantable Cardioverter Defibrillators, 91238-91239 [2016-30283]
Download as PDF
91238
Federal Register / Vol. 81, No. 242 / Friday, December 16, 2016 / Notices
By the Board, Rachel D. Campbell,
Director, Office of Proceedings.
Raina S. Contee,
Clearance Clerk.
[FR Doc. 2016–30249 Filed 12–15–16; 8:45 am]
BILLING CODE 4915–01–P
DEPARTMENT OF TRANSPORTATION
Federal Aviation Administration
Notice of Release From Quitclaim Deed
and Grant Assurance Obligations at
Reno Stead Airport, Reno, Washoe
County, Nevada
Federal Aviation
Administration, DOT.
ACTION: Notice of a land release.
AGENCY:
The Federal Aviation
Administration (FAA) proposes to rule
and invites public comment on the
application for a land release of
approximately 0.58 acres of airport
property and associated 15-foot-wide
access easement owned by Reno Stead
Airport, Reno, Washoe County, Nevada
from the airport use provisions of the
Grant Agreement Assurances since the
land is not needed for airport purposes.
The subject property is located
approximately 0.5 miles from the Reno
Stead Airport and has no identified
airport-related purpose. The airport will
be compensated for the fair market
value of the released property. Reuse of
the property will not interfere with the
airport or its operation, thereby
protecting the interests of civil aviation.
DATES: Comments must be received on
or before January 17, 2017.
FOR FURTHER INFORMATION CONTACT:
Comments on the request may be mailed
or delivered to the FAA at the following
address: Mike N. Williams, Manager,
Airports District Office, Federal
Register Comment, Federal Aviation
Administration, Phoenix Airports
District Office, 3800 N. Central Avenue,
Suite 1025, Phoenix, Arizona 85012. In
addition, one copy of the comment
submitted to the FAA must be mailed or
delivered to Ms. Lissa Butterfield,
Senior Airport Planner, Reno-Tahoe
Airport Authority, P.O. Box 12490,
Reno, NV 89510.
SUPPLEMENTARY INFORMATION: In
accordance with the Wendell H. Ford
Aviation Investment and Reform Act for
the 21st Century (AIR 21), Public Law
106–181 (Apr. 5, 2000; 114 Stat. 61),
this notice must be published in the
Federal Register 30 days before the DOT
Secretary may waive any condition
imposed on a federally obligated airport
by surplus property conveyance deeds
or grant agreements.
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:42 Dec 15, 2016
Jkt 241001
The following is a brief overview of
the request:
The Reno-Tahoe Airport Authority
(RTAA) requested a release from the
provisions of the Grant Agreement
Assurances to permit the disposal of
approximately 0.58 acres of land near
Reno Stead Airport, Reno, Washoe
County, Nevada to permit Artisan
Communities to incorporate the 0.58acre property into their approximately
47-acre community development. The
property is located in an area zoned
residential and the release will
eliminate RTAA’s future liability for the
property since the property cannot be
redeveloped for a commercial or airport
purpose. The airport will be
compensated for the fair market value of
the released property. The RTAA
supports disposal of the parcel, which
has no identified airport-related purpose
or future use, especially since it is 0.5
miles from the airport. Reuse of the
property will not interfere with the
airport or its operation, thereby
protecting the interests of civil aviation.
Based on the benefits of fair
compensation in exchange for the land,
the interests of civil aviation will be
properly served.
Issued in Hawthorne, California, on
December 8, 2016.
Brian Q. Armstrong,
Manager, Safety and Standards Branch,
Airports Division, Western-Pacific Region.
[FR Doc. 2016–30210 Filed 12–15–16; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2016–0175]
Qualification of Drivers; Exemption
Applications; Implantable Cardioverter
Defibrillators
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of denials of exemption
applications.
AGENCY:
FMCSA announces its
decision to deny applications from 11
individuals seeking exemptions from
the Federal cardiovascular standard
applicable to interstate truck and bus
drivers and discusses the reasons for the
denials. The Agency reviewed the
medical information of each of the
individuals who applied for an
implantable cardioverter defibrillator
(ICD) exemption. Based on a review of
the applications and following an
opportunity for public comment,
FMCSA has concluded that the 11
SUMMARY:
PO 00000
Frm 00124
Fmt 4703
Sfmt 4703
individuals in the notice did not
demonstrate they could achieve a level
of safety that is equivalent to, or greater
than, the level of safety that would be
obtained by complying with the
regulation.
DATES: Denial letters were sent to each
of the individuals listed in this notice
on October 11, 2016.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief Medical
Programs Division, 202–366–4001, U.S.
Department of Transportation, FMCSA,
1200 New Jersey Avenue SE., Room
W64–224, Washington, DC 20590–0001.
Office hours are from 8:30 a.m. to 5 p.m.
Monday through Friday, except Federal
holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the Federal Motor Carrier Safety
Regulations for up to five years if it
finds ‘‘such exemption would likely
achieve a level of safety that is
equivalent to or greater than the level
that would be achieved absent such
exemption.’’ FMCSA can renew
exemptions for up to an additional five
years at the end of each five-year
period.1
On August 8, 2016, FMCSA published
for public notice and comment, FMCSA
2016–0175, listing 11 individuals
seeking exemptions for ICDs.
Accordingly, the Agency has evaluated
each applicant’s request to determine
whether granting an exemption will
achieve the required level of safety
mandated by statute.
Evaluation Criteria—Cardiovascular
Medical Standard and Advisory
Criteria
The individuals included in this
notice have requested an exemption
from the provisions of 49 CFR
391.41(b)(4), which applies to drivers
who operate CMVs in interstate
commerce, as defined in 49 CFR 390.5.
Section 391.41(b)(4) states that:
A person is physically qualified to drive a
commercial motor vehicle if—
*
*
*
*
*
that person has no current clinical diagnosis
of myocardial infarction, angina pectoris,
coronary insufficiency, thrombosis, or any
other cardiovascular disease of a variety
known to be accompanied by syncope [a
temporary loss of consciousness due to a
sudden decline in blood flow to the brain],
dyspnea [shortness of breath], collapse, or
congestive cardiac failure.
1 49 U.S.C. 31315(b), as amended by section
5206(a) of the FAST Act, Public Law 114–94, div.
A, title V, 129 Stat. 1537 (Dec. 4, 2015).
E:\FR\FM\16DEN1.SGM
16DEN1
Federal Register / Vol. 81, No. 242 / Friday, December 16, 2016 / Notices
The FMCSA provides medical
advisory criteria as recommendations
for use by medical examiners in
determining whether drivers with
certain medical conditions and drivers
who have undergone certain procedures
and/or treatments should be certified to
operate CMVs in interstate commerce in
accordance with the various physical
qualification standards in 49 CFR part
391, subpart E. The advisory criteria are
currently set out in Appendix A to 49
CFR part 391. The advisory criteria for
section 391.41(b)(4) provide, in part,
that:
mstockstill on DSK3G9T082PROD with NOTICES
The term ‘‘has no current clinical diagnosis
of’’ is specifically designed to encompass: ‘‘a
clinical diagnosis of’’ (1) a current
cardiovascular condition, or (2) a
cardiovascular condition which has not fully
stabilized regardless of the time limit. The
term ‘‘known to be accompanied by’’ is
designed to include a clinical diagnosis of a
cardiovascular disease (1) which is
accompanied by symptoms of syncope,
dyspnea, collapse or congestive cardiac
failure; and/or (2) which is likely to cause
syncope, dyspnea, collapse, or congestive
cardiac failure.
It is the intent of the Federal Motor Carrier
Safety Regulations to render unqualified, a
driver who has a current cardiovascular
disease which is accompanied by and/or
likely to cause symptoms of syncope,
dyspnea, collapse, or congestive cardiac
failure. However, the subjective decision of
whether the nature and severity of an
individual’s condition will likely cause
symptoms of cardiovascular insufficiency is
on an individual basis and qualification rests
with the medical examiner and the motor
carrier.
In the case of persons with ICDs, the
underlying condition for which the ICD
was implanted places the individual at
high risk for syncope (a transient loss of
consciousness) or other unpredictable
events known to result in gradual or
sudden incapacitation. ICDs may
discharge, which could result in loss of
ability to safely control a CMV. See the
Evidence Report on ‘‘Cardiovascular
Disease and Commercial Motor Vehicle
Driver Safety,’’ April 2007.2 A focused
research report entitled ‘‘Implantable
Cardioverter Defibrillators and the
Impact of a Shock on a Patient When
Deployed,’’ completed for the FMCSA
in December 2014, indicates that the
available scientific data on persons with
ICDs and CMV driving does not support
that persons with ICDs who operate
CMVs are able to meet an equal or
greater level of safety and upholds the
findings of the April 2007 report. Copies
of the April 2007 report and the
2 Now available at https://ntl.bts.gov/lib/30000/
30100/30123/Final_CVD_Evidence_Report_v2.pdf.
VerDate Sep<11>2014
18:42 Dec 15, 2016
Jkt 241001
December 2014 report are included in
the docket for this notice.
Discussion of Public Comments
On August 8, 2016, FMCSA published
in a Federal Register Notice the names
of 11 individuals seeking ICD
exemption and requested public
comment. The public comment period
closed on September 7, 2016. A total of
29 commenters responded to the notice.
Each of the comments was favorable
towards the applicants continuing to
drive CMV’s with ICD’s. Many
commenters believed that the
individuals seeking exemptions were
safe drivers with safe professional work
histories, and that their exemption
request should be considered on an
individual case basis based on merit.
Several commenters expressed that
individual driving records and
experience should be factors in allowing
persons with ICD’s to operate CMVs.
FMCSA’s Response
FMCSA acknowledges the
commenters’ concerns. The Agency
reviews and considers each applicant’s
request individually. Based on the
available medical literature cited above,
however, FMCSA believes that a driver
with an ICD is at risk for incapacitation
if the device discharges. This risk is
combined with the risks associated with
the underlying cardiovascular condition
for which the ICD has been implanted
as a primary or secondary preventive
measure.
Conclusion
FMCSA evaluated the 11 individual
exemption requests on their merits,
available data from Evidence Reports
and Medical Expert Panel opinions on
the impact of ICDs on Commercial
Motor Vehicle driving, and the public
comments received. The Agency has
determined that the available medical
literature and data does not support a
conclusion that granting these
exemptions would achieve a level of
safety equivalent to or greater than the
level of safety maintained without the
exemptions. Each applicant has, prior to
this notice, received a letter of final
disposition on his/her exemption
request. Those decision letters fully
outlined the basis for the denial and
constitute final Agency action. The list
published today summarizes the
Agency’s recent denials as required
under 49 U.S.C. 31315(b)(4).
The following 11 applicants are
denied exemptions from the
cardiovascular standard.
Charles R. Allen (MI)
William Blake (NH)
Roosevelt Tyrone Brown (SC)
PO 00000
Frm 00125
Fmt 4703
Sfmt 4703
91239
Kevin Coulter (CA)
John Dudar (CT)
Timothy Godwin (NC)
James Goslee (MD)
Richard Hacker (MD)
Kathryn Kosse (AZ)
Joseph Skrzyniarz (MI)
Wylanne Deon Sanders (IL)
Issued on: December 8, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016–30283 Filed 12–15–16; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–1999–6480; FMCSA–
2001–11426; FMCSA–2002–11714; FMCSA–
2002–12844; FMCSA–2003–16564; FMCSA–
2004–19477; FMCSA–2005–21711; FMCSA–
2005–22727; FMCSA–2005–23099; FMCSA–
2006–23773; FMCSA–2006–24015; FMCSA–
2008–0021; FMCSA–2009–0011; FMCSA–
2009–0303; FMCSA–2009–0321; FMCSA–
2010–0050; FMCSA–2011–0142; FMCSA–
2011–0299; FMCSA–2011–0366; FMCSA–
2011–0379; FMCSA–2011–0380; FMCSA–
2012–0039; FMCSA–2013–0174; FMCSA–
2014–0002; FMCSA–2014–0003; FMCSA–
2014–0004]
Qualification of Drivers; Exemption
Applications; Vision
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of renewal of
exemptions; request for comments.
AGENCY:
FMCSA announces its
decision to renew the exemptions from
the vision requirement in the Federal
Motor Carrier Safety Regulations for 131
individuals. FMCSA has statutory
authority to exempt individuals from
the vision requirement if the
exemptions granted will not
compromise safety. The Agency has
concluded that granting these
exemption renewals will provide a level
of safety that is equivalent to or greater
than the level of safety maintained
without the exemptions for these
commercial motor vehicle (CMV)
drivers.
SUMMARY:
Each group of renewed
exemptions was effective from the dates
stated in the discussions below.
Comments must be received on or
before January 17, 2017.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) numbers: Docket No.
[Docket No. FMCSA–1999–6480;
FMCSA–2001–11426; FMCSA–2002–
11714; FMCSA–2002–12844; FMCSA–
DATES:
E:\FR\FM\16DEN1.SGM
16DEN1
Agencies
[Federal Register Volume 81, Number 242 (Friday, December 16, 2016)]
[Notices]
[Pages 91238-91239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30283]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2016-0175]
Qualification of Drivers; Exemption Applications; Implantable
Cardioverter Defibrillators
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of denials of exemption applications.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to deny applications from 11
individuals seeking exemptions from the Federal cardiovascular standard
applicable to interstate truck and bus drivers and discusses the
reasons for the denials. The Agency reviewed the medical information of
each of the individuals who applied for an implantable cardioverter
defibrillator (ICD) exemption. Based on a review of the applications
and following an opportunity for public comment, FMCSA has concluded
that the 11 individuals in the notice did not demonstrate they could
achieve a level of safety that is equivalent to, or greater than, the
level of safety that would be obtained by complying with the
regulation.
DATES: Denial letters were sent to each of the individuals listed in
this notice on October 11, 2016.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief Medical
Programs Division, 202-366-4001, U.S. Department of Transportation,
FMCSA, 1200 New Jersey Avenue SE., Room W64-224, Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday,
except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for up to five years
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' FMCSA can renew exemptions for up to an
additional five years at the end of each five-year period.\1\
---------------------------------------------------------------------------
\1\ 49 U.S.C. 31315(b), as amended by section 5206(a) of the
FAST Act, Public Law 114-94, div. A, title V, 129 Stat. 1537 (Dec.
4, 2015).
---------------------------------------------------------------------------
On August 8, 2016, FMCSA published for public notice and comment,
FMCSA 2016-0175, listing 11 individuals seeking exemptions for ICDs.
Accordingly, the Agency has evaluated each applicant's request to
determine whether granting an exemption will achieve the required level
of safety mandated by statute.
Evaluation Criteria--Cardiovascular Medical Standard and Advisory
Criteria
The individuals included in this notice have requested an exemption
from the provisions of 49 CFR 391.41(b)(4), which applies to drivers
who operate CMVs in interstate commerce, as defined in 49 CFR 390.5.
Section 391.41(b)(4) states that:
A person is physically qualified to drive a commercial motor
vehicle if--
* * * * *
that person has no current clinical diagnosis of myocardial
infarction, angina pectoris, coronary insufficiency, thrombosis, or
any other cardiovascular disease of a variety known to be
accompanied by syncope [a temporary loss of consciousness due to a
sudden decline in blood flow to the brain], dyspnea [shortness of
breath], collapse, or congestive cardiac failure.
[[Page 91239]]
The FMCSA provides medical advisory criteria as recommendations for
use by medical examiners in determining whether drivers with certain
medical conditions and drivers who have undergone certain procedures
and/or treatments should be certified to operate CMVs in interstate
commerce in accordance with the various physical qualification
standards in 49 CFR part 391, subpart E. The advisory criteria are
currently set out in Appendix A to 49 CFR part 391. The advisory
criteria for section 391.41(b)(4) provide, in part, that:
The term ``has no current clinical diagnosis of'' is
specifically designed to encompass: ``a clinical diagnosis of'' (1)
a current cardiovascular condition, or (2) a cardiovascular
condition which has not fully stabilized regardless of the time
limit. The term ``known to be accompanied by'' is designed to
include a clinical diagnosis of a cardiovascular disease (1) which
is accompanied by symptoms of syncope, dyspnea, collapse or
congestive cardiac failure; and/or (2) which is likely to cause
syncope, dyspnea, collapse, or congestive cardiac failure.
It is the intent of the Federal Motor Carrier Safety Regulations
to render unqualified, a driver who has a current cardiovascular
disease which is accompanied by and/or likely to cause symptoms of
syncope, dyspnea, collapse, or congestive cardiac failure. However,
the subjective decision of whether the nature and severity of an
individual's condition will likely cause symptoms of cardiovascular
insufficiency is on an individual basis and qualification rests with
the medical examiner and the motor carrier.
In the case of persons with ICDs, the underlying condition for
which the ICD was implanted places the individual at high risk for
syncope (a transient loss of consciousness) or other unpredictable
events known to result in gradual or sudden incapacitation. ICDs may
discharge, which could result in loss of ability to safely control a
CMV. See the Evidence Report on ``Cardiovascular Disease and Commercial
Motor Vehicle Driver Safety,'' April 2007.\2\ A focused research report
entitled ``Implantable Cardioverter Defibrillators and the Impact of a
Shock on a Patient When Deployed,'' completed for the FMCSA in December
2014, indicates that the available scientific data on persons with ICDs
and CMV driving does not support that persons with ICDs who operate
CMVs are able to meet an equal or greater level of safety and upholds
the findings of the April 2007 report. Copies of the April 2007 report
and the December 2014 report are included in the docket for this
notice.
---------------------------------------------------------------------------
\2\ Now available at https://ntl.bts.gov/lib/30000/30100/30123/Final_CVD_Evidence_Report_v2.pdf.
---------------------------------------------------------------------------
Discussion of Public Comments
On August 8, 2016, FMCSA published in a Federal Register Notice the
names of 11 individuals seeking ICD exemption and requested public
comment. The public comment period closed on September 7, 2016. A total
of 29 commenters responded to the notice. Each of the comments was
favorable towards the applicants continuing to drive CMV's with ICD's.
Many commenters believed that the individuals seeking exemptions were
safe drivers with safe professional work histories, and that their
exemption request should be considered on an individual case basis
based on merit. Several commenters expressed that individual driving
records and experience should be factors in allowing persons with ICD's
to operate CMVs.
FMCSA's Response
FMCSA acknowledges the commenters' concerns. The Agency reviews and
considers each applicant's request individually. Based on the available
medical literature cited above, however, FMCSA believes that a driver
with an ICD is at risk for incapacitation if the device discharges.
This risk is combined with the risks associated with the underlying
cardiovascular condition for which the ICD has been implanted as a
primary or secondary preventive measure.
Conclusion
FMCSA evaluated the 11 individual exemption requests on their
merits, available data from Evidence Reports and Medical Expert Panel
opinions on the impact of ICDs on Commercial Motor Vehicle driving, and
the public comments received. The Agency has determined that the
available medical literature and data does not support a conclusion
that granting these exemptions would achieve a level of safety
equivalent to or greater than the level of safety maintained without
the exemptions. Each applicant has, prior to this notice, received a
letter of final disposition on his/her exemption request. Those
decision letters fully outlined the basis for the denial and constitute
final Agency action. The list published today summarizes the Agency's
recent denials as required under 49 U.S.C. 31315(b)(4).
The following 11 applicants are denied exemptions from the
cardiovascular standard.
Charles R. Allen (MI)
William Blake (NH)
Roosevelt Tyrone Brown (SC)
Kevin Coulter (CA)
John Dudar (CT)
Timothy Godwin (NC)
James Goslee (MD)
Richard Hacker (MD)
Kathryn Kosse (AZ)
Joseph Skrzyniarz (MI)
Wylanne Deon Sanders (IL)
Issued on: December 8, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016-30283 Filed 12-15-16; 8:45 am]
BILLING CODE 4910-EX-P